JPRN-UMIN000008046
Completed
未知
Clinical prospective study to investigate efficacy of NK cell therapy for malignant tumors. - Clinical prospective study to investigate efficacy of NK cell therapy for malignant tumors.
Seta Clinic Group0 sites20 target enrollmentMay 28, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Seta Clinic Group
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have: (1\) Pulmonary fibrosis or interstitial pneumonia, or history or predisposition of them; (2\) Serious drug allergy; (3\) Positive for HIV or HTLV\-1; (4\) Active autoimmune disease; (5\) Continuous systemic administration of steroids; (6\) Other cancers; (7\) Active infections; (8\) Pregnant or lactating; (9\) T cell, NK cell lymphoma and leukemia; (10\) Serious cardiac disease; (11\) Any reason why, in the opinion of the investigator, the patient should not participate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical prospective study to investigate efficacy and safety of immune-cell therapy for malignant tumorsMalignant tumorJPRN-UMIN000004610Kanazawa university600
Completed
Not Applicable
Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapyMalignant tumor (all HLA types)JPRN-UMIN000009447Seta Clinic Group5
Completed
Not Applicable
The prospective study of the clinical efficacy/adverse event of regorafenib in unresectable metastatic and advanced colorectal cancerColorectal cancerJPRN-UMIN000015404Department of Clinical Oncology, Akita University Hospital50
Active, not recruiting
Not Applicable
Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis - Tretinoin bei AKactinic keratosisMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisEUCTR2007-000093-23-DEAlmirall Hermal GmbH
Active, not recruiting
Not Applicable
Clinical trial to investigate clinical efficacy and tolerability of Verrumal in actinic keratosis (PoC) - Verrumal in AKEUCTR2006-005432-24-DEHermal Kurt Herrmann GmbH & Co OHG15